Showing results (11-20 of 129) with videos related to
Sort By:
Pageof 13
Drug Safety|December 12, 2001
Therapeutic drug monitoring databases for postmarketing surveillance of drug-drug interactionsM Gex-Fabry, A E Balant-Gorgia, L P BalantSchweizer Archiv Fur Neurologie Und Psychiatrie (Zurich, Switzerland : 1985)|January 1, 1989
[Epidemiology of psychotropic drugs: possibilities and limits of studies on therapeutic monitoring]L P Balant, A E Balant-Gorgia, M Gex-FabryTherapie|July 1, 1996
Therapeutic drug monitoring and drug-drug interactions: a pharmacoepidemiological perspectiveA E Balant-Gorgia, M Gex-Fabry, L P BalantTherapeutic Drug Monitoring|February 1, 1997
Therapeutic drug monitoring databases for postmarketing surveillance of drug-drug interactions: evaluation of a paired approach for psychotropic medicationM Gex-Fabry, A E Balant-Gorgia, L P BalantTherapeutic Drug Monitoring|February 1, 1995
Potential of concentration monitoring data for a short half-life drug: analysis of pharmacokinetic variability for moclobemideM Gex-Fabry, A E Balant-Gorgia, L P BalantClinical Pharmacokinetics|June 1, 1991
Clinical pharmacokinetics of clomipramineA E Balant-Gorgia, M Gex-Fabry, L P BalantTherapeutic Drug Monitoring|March 2, 1999
Therapeutic drug monitoring of risperidone using a new, rapid HPLC method: reappraisal of interindividual variability factorsA E Balant-Gorgia, M Gex-Fabry, C Genet, et al.L'Encephale|April 25, 2006
[Validation of the QFS measuring the frequency and satisfaction in social behaviours in psychiatric adult population]A Zanello, B Weber Rouget, M Gex-Fabry, et al.European Journal of Drug Metabolism and Pharmacokinetics|April 1, 1987
Stereoselective disposition of flupentixol: influence on steady-state plasma concentrations in schizophrenic patientsA E Balant-Gorgia, L P Balant, M Gex-Fabry, et al.Therapeutic Drug Monitoring|April 1, 1992
Persistent impairment of clomipramine demethylation in recently detoxified alcoholic patientsA E Balant-Gorgia, M Gay, M Gex-Fabry, et al.Pageof 13